Awad, M., Spigel, D., Garon, E., Waqar, S., Lisberg, A., Moles, M., Tepper, J., Lamb, A., Wanamaker, A., Khondker, Z., Srouji, J., Dong, J., Poran, A., Balogh, K., Bushway, M., DeMario, M., Srinivasan, L., Gaynor, R., & Govindan, R. (n.d.). 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC. Journal for immunotherapy of cancer, 8, A222. http://access.bl.uk/ark:/81055/vdc_100144709942.0x000004